Adrain, C., Creagh, E.M., and Martin, S.J., 2001. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20, 6627-36.
Alomar, J., Lebert, A., and Montel, M.C., 2008. Effect of temperature and pH on growth of Staphylococcus aureus in co-culture with Lactococcus garvieae. Curr Microbiol 56, 408-12.
Alvero, A.B., O'Malley, D., Brown, D., Kelly, G., Garg, M., Chen, W., Rutherford, T., and Mor, G., 2006. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 106, 599-608.
Ao, Z.H., Xu, Z.H., Lu, Z.M., Xu, H.Y., Zhang, X.M., and Dou, W.F., 2009. Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J Ethnopharmacol 121, 194-212.
Ashkenazi, A., and Dixit, V.M., 1998. Death receptors: signaling and modulation. Science 281, 1305-8.
Ashkenazi, A., Pai, R.C., Fong, S., Leung, S., Lawrence, D.A., Marsters, S.A., Blackie, C., Chang, L., McMurtrey, A.E., Hebert, A., DeForge, L., Koumenis, I.L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., and Schwall, R.H., 1999. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104, 155-62.
Bougie, O., and Weberpals, J.I., 2011. Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review. Int J Surg Oncol 2011, 374012.
Brautigam, K., Biernath-Wupping, J., Bauerschlag, D.O., von Kaisenberg, C.S., Jonat, W., Maass, N., Arnold, N., and Meinhold-Heerlein, I., 2011. Combined treatment with TRAIL and PPARgamma ligands overcomes chemoresistance of ovarian cancer cell lines. J Cancer Res Clin Oncol 137, 875-86.
Chandrasekaran, E.V., Xue, J., Neelamegham, S., and Matta, K.L., 2006. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydr Res 341, 983-94.
Chang, H.L., Hsu, H.K., Su, J.H., Wang, P.H., Chung, Y.F., Chia, Y.C., Tsai, L.Y., Wu, Y.C., and Yuan, S.S., 2006. The fractionated Toona sinensis leaf extract induces apoptosis of human ovarian cancer cells and inhibits tumor growth in a murine xenograft model. Gynecol Oncol 102, 309-14.
Chang, C.Y., Huang, Z.N., Yu, H.H., Chang, L.H., Li, S.L., Chen, Y.P., Lee, K.Y., and Chuu, J.J., 2008. The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. J Ethnopharmacol 118, 387-95.
Chang, J.M., Lee, Y.R., Hung, L.M., Liu, S.Y., Kuo, M.T., Wen, W.C., and Chen, P., 2011. An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice. Evid Based Complement Alternat Med 2011, 465894.
Chen, V.W., Ruiz, B., Killeen, J.L., Cote, T.R., Wu, X.C., and Correa, C.N., 2003. Pathology and classification of ovarian tumors. Cancer 97, 2631-42.
Cheng, J.J., Huang, N.K., Chang, T.T., Wang, D.L., and Lu, M.K., 2005. Study for anti-angiogenic activities of polysaccharides isolated from Antrodia cinnamomea in endothelial cells. Life Sci 76, 3029-42.
Dai, Z., Yin, J., He, H., Li, W., Hou, C., Qian, X., Mao, N., and Pan, L., 2010. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines. Proteomics 10, 3789-99.
Daly, M.B., Axilbund, J.E., Buys, S., Crawford, B., Farrell, C.D., Friedman, S., Garber, J.E., Goorha, S., Gruber, S.B., Hampel, H., Kaklamani, V., Kohlmann, W., Kurian, A., Litton, J., Marcom, P.K., Nussbaum, R., Offit, K., Pal, T., Pasche, B., Pilarski, R., Reiser, G., Shannon, K.M., Smith, J.R., Swisher, E., and Weitzel, J.N., 2010. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8, 562-94.
Dzubak, P., Hajduch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M., and Sarek, J., 2006. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep 23, 394-411.
Fehsel, K., Kolb-Bachofen, V., and Kroncke, K.D., 2003. Necrosis is the predominant type of islet cell death during development of insulin-dependent diabetes mellitus in BB rats. Lab Invest 83, 549-59.
Ferrara, N., 2000. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11, 617-24.
Fesik, S.W., 2005. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5, 876-85.
Fuchs, D.A., and Johnson, R.K., 1978. Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep 62, 1219-22.
Fung-Kee-Fung, M., Oliver, T., Elit, L., Oza, A., Hirte, H.W., and Bryson, P., 2007. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14, 195-208.
Geethangili, M., and Tzeng, Y.M., 2011. Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds. Evid Based Complement Alternat Med 2011, 212641.
Harries, M., and Gore, M., 2002. Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis. Lancet Oncol 3, 529-36.
Hartwell, L.H., 2002. Nobel Lecture. Yeast and cancer. Biosci Rep 22, 373-94.
Hassan, M.K., Watari, H., Christenson, L., Bettuzzi, S., and Sakuragi, N., 2011. Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel. Tumour Biol 32, 1031-47.
Herzog, T.J., and Pothuri, B., 2006. Ovarian cancer: a focus on management of recurrent disease. Nat Clin Pract Oncol 3, 604-11.
Ho, J.W., Leung, Y.K., and Chan, C.P., 2002. Herbal medicine in the treatment of cancer. Curr Med Chem Anticancer Agents 2, 209-14.
Horak, P., Pils, D., Haller, G., Pribill, I., Roessler, M., Tomek, S., Horvat, R., Zeillinger, R., Zielinski, C., and Krainer, M., 2005a. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer. Mol Cancer Res 3, 335-43.
Horak, P., Pils, D., Kaider, A., Pinter, A., Elandt, K., Sax, C., Zielinski, C.C., Horvat, R., Zeillinger, R., Reinthaller, A., and Krainer, M., 2005b. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5. Clin Cancer Res 11, 8585-91.
Hsieh, Y.C., Rao, Y.K., Wu, C.C., Huang, C.Y., Geethangili, M., Hsu, S.L., and Tzeng, Y.M., 2010. Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway. Chem Res Toxicol 23, 1256-67.
Jang, E.R., Kim, Y.J., Myung, S.C., Kim, W., and Lee, C.S., 2011. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines. Mol Cell Biochem 353, 1-11.
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., and Thun, M.J., 2006. Cancer statistics, 2006. CA Cancer J Clin 56, 106-30.
Jo, M., Park, M.H., Kollipara, P.S., An, B.J., Song, H.S., Han, S.B., Kim, J.H., Song, M.J., and Hong, J.T., 2012. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol 258, 72-81.
Kandala, P.K., and Srivastava, S.K., 2012. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). BMC Med 10, 9.
Kelly, M.G., Alvero, A.B., Chen, R., Silasi, D.A., Abrahams, V.M., Chan, S., Visintin, I., Rutherford, T., and Mor, G., 2006. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66, 3859-68.
Khaider, N.G., Lane, D., Matte, I., Rancourt, C., and Piche, A., 2012. Targeted ovarian cancer treatment: the TRAILs of resistance. Am J Cancer Res 2, 75-92.
Kim, K.H., Xie, Y., Tytler, E.M., Woessner, R., Mor, G., and Alvero, A.B., 2009. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells. J Transl Med 7, 63.
Kim, R., Emi, M., Tanabe, K., Uchida, Y., and Arihiro, K., 2006. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment. Eur J Surg Oncol 32, 269-77.
Kim, Y.J., Lee, S.A., Myung, S.C., Kim, W., and Lee, C.S., 2012. Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins. Mol Cell Biochem 359, 33-43.
King, M.C., Marks, J.H., and Mandell, J.B., 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643-6.
Krysko, O., De Ridder, L., and Cornelissen, M., 2004. Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis 9, 495-500.
Kumar, V.B., Yuan, T.C., Liou, J.W., Yang, C.J., Sung, P.J., and Weng, C.F., 2011. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles. Mutat Res 707, 42-52.
Kuroda, H., Mandai, M., Konishi, I., Yura, Y., Tsuruta, Y., Hamid, A.A., Nanbu, K., Matsushita, K., and Mori, T., 1998. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by hCG. Int J Cancer 76, 571-8.
Kuwana, T., Bouchier-Hayes, L., Chipuk, J.E., Bonzon, C., Sullivan, B.A., Green, D.R., and Newmeyer, D.D., 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17, 525-35.
Lacey, J.V., Jr., Mink, P.J., Lubin, J.H., Sherman, M.E., Troisi, R., Hartge, P., Schatzkin, A., and Schairer, C., 2002. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288, 334-41.
Lancaster, J.M., Sayer, R., Blanchette, C., Calingaert, B., Whitaker, R., Schildkraut, J., Marks, J., and Berchuck, A., 2003. High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival. Clin Cancer Res 9, 762-6.
Lane, D., Cote, M., Grondin, R., Couture, M.C., and Piche, A., 2006. Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3. Mol Cancer Ther 5, 509-21.
Lavrik, I., Golks, A., and Krammer, P.H., 2005. Death receptor signaling. J Cell Sci 118, 265-7.
Lee, I.H., Huang, R.L., Chen, C.T., Chen, H.C., Hsu, W.C., and Lu, M.K., 2002. Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol Lett 209, 63-7.
Lee, M.H., Choi, B.Y., Kundu, J.K., Shin, Y.K., Na, H.K., and Surh, Y.J., 2009. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res 69, 7449-58.
Li, H.Z., Wang, Y., Gao, Y., Shao, J., Zhao, X.L., Deng, W.M., Liu, Y.X., Yang, J., and Yao, Z., 2008. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6, 917-28.
Liu, D.Z., Liang, Y.C., Lin, S.Y., Lin, Y.S., Wu, W.C., Hou, W.C., and Su, C.H., 2007a. Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-chih) in spontaneously hypertensive rats. Biosci Biotechnol Biochem 71, 23-30.
Liu, D.Z., Liang, H.J., Chen, C.H., Su, C.H., Lee, T.H., Huang, C.T., Hou, W.C., Lin, S.Y., Zhong, W.B., Lin, P.J., Hung, L.F., and Liang, Y.C., 2007b. Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action. J Ethnopharmacol 113, 45-53.
Liu, F.S., Yang, P.Y., Hu, D.N., Huang, Y.W., and Chen, M.J., 2011. Antrodia camphorata induces apoptosis and enhances the cytotoxic effect of paclitaxel in human ovarian cancer cells. Int J Gynecol Cancer 21, 1172-9.
Lu, M.K., Cheng, J.J., Lai, W.L., Lin, Y.J., and Huang, N.K., 2008. Fermented Antrodia cinnamomea extract protects rat PC12 cells from serum deprivation-induced apoptosis: the role of the MAPK family. J Agric Food Chem 56, 865-74.
Luo, Y., Yi, Y., and Yao, Z., 2009. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells. Cancer Invest 27, 960-70.
Lv, W., Sheng, X., Chen, T., Xu, Q., and Xie, X., 2008. Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway. J Biomed Biotechnol 2008, 394802.
Mandai, M., Konishi, I., Kuroda, H., Fukumoto, M., Komatsu, T., Yamamoto, S., Nanbu, K., Rao, C.V., and Mori, T., 1997. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 33, 1501-7.
McGowan, C.H., 2003. Regulation of the eukaryotic cell cycle. Prog Cell Cycle Res 5, 1-4.
Melichar, B., Patenia, R., Gallardo, S., Melicharova, K., Hu, W., and Freedman, R.S., 2007. Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines. Gynecol Oncol 104, 707-13.
Monk, B.J., Choi, D.C., Pugmire, G., and Burger, R.A., 2005a. Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer. Gynecol Oncol 96, 902-905.
Monk, B.J., Choi, D.C., Pugmire, G., and Burger, R.A., 2005b. Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer. Gynecol Oncol 96, 902-5.
Monk, B.J., Han, E., Josephs-Cowan, C.A., Pugmire, G., and Burger, R.A., 2006a. Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer. Gynecol Oncol 102, 140-144.
Monk, B.J., Han, E., Josephs-Cowan, C.A., Pugmire, G., and Burger, R.A., 2006b. Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer. Gynecol Oncol 102, 140-4.
Moye-Rowley, W.S., 2005. Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. Gene 354, 15-21.
Ozols, R.F., Bookman, M.A., Connolly, D.C., Daly, M.B., Godwin, A.K., Schilder, R.J., Xu, X., and Hamilton, T.C., 2004. Focus on epithelial ovarian cancer. Cancer Cell 5, 19-24.
Perez, R.P., Godwin, A.K., Hamilton, T.C., and Ozols, R.F., 1991. Ovarian cancer biology. Semin Oncol 18, 186-204.
Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., and Liotta, L.A., 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-7.
Petronelli, A., Saulle, E., Pasquini, L., Petrucci, E., Mariani, G., Biffoni, M., Ferretti, G., Scambia, G., Benedetti-Panici, P., Greggi, S., Cognetti, F., Russo, M.A., Sporn, M., and Testa, U., 2009. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. Cancer Lett 282, 214-28.
Ptak, A., Wrobel, A., and Gregoraszczuk, E.L., 2011. Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol Lett 202, 30-5.
Rao, Y.K., Wu, A.T., Geethangili, M., Huang, M.T., Chao, W.J., Wu, C.H., Deng, W.P., Yeh, C.T., and Tzeng, Y.M., 2011. Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells. Chem Res Toxicol 24, 238-45.
Sarraf, S., Tejada, R., Abawi, M., Oberst, M., Dennis, T., Simon, K.C., and Blancato, J., 2005. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray. Cancer Genet Cytogenet 161, 63-9.
Schiff, P.B., and Horwitz, S.B., 1980. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 77, 1561-5.
Selvendiran, K., Tong, L., Bratasz, A., Kuppusamy, M.L., Ahmed, S., Ravi, Y., Trigg, N.J., Rivera, B.K., Kalai, T., Hideg, K., and Kuppusamy, P., 2010. Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts. Mol Cancer Ther 9, 1169-79.
Shu, C.-H., and Lung, M.-Y., 2008. Effect of culture pH on the antioxidant properties of Antrodia camphorata in submerged culture. Journal of the Chinese Institute of Chemical Engineers 39, 1-8.
Singh, R.K., Lange, T.S., Kim, K.K., and Brard, L., 2011. A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest New Drugs 29, 63-72.
Song, T.Y., and Yen, G.C., 2003. Protective effects of fermented filtrate from Antrodia camphorata in submerged culture against CCl4-induced hepatic toxicity in rats. J Agric Food Chem 51, 1571-7.
Sun, H., Yu, T., and Li, J., 2011. Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition. Cancer Lett 310, 118-28.
Sun, S.C., Hsu, P.J., Wu, F.J., Li, S.H., Lu, C.H., and Luo, C.W., 2010. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. J Biol Chem 285, 3758-65.
Tai, J., Cheung, S., Chan, E., and Hasman, D., 2010. Inhibition of human ovarian cancer cell lines by devil's club Oplopanax horridus. J Ethnopharmacol 127, 478-85.
Takai, N., Ueda, T., Nishida, M., Nasu, K., and Narahara, H., 2008. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells. Gynecol Oncol 109, 107-14.
Tounekti, O., Belehradek, J., Jr., and Mir, L.M., 1995. Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 217, 506-16.
Tyagi, A., Singh, R.P., Agarwal, C., Siriwardana, S., Sclafani, R.A., and Agarwal, R., 2005. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26, 1978-87.
Vlad, A.M., Budiu, R.A., Lenzner, D.E., Wang, Y., Thaller, J.A., Colonello, K., Crowley-Nowick, P.A., Kelley, J.L., Price, F.V., and Edwards, R.P., 2010. A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer. Cancer Immunol Immunother 59, 293-301.
Wang, S., and El-Deiry, W.S., 2003. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22, 8628-33.
Yang, Y.C., Tsao, Y.P., Ho, T.C., and Choung, I.P., 2007. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines. Int J Gynecol Cancer 17, 418-25.
Yue, P.Y., Wong, Y.Y., Chan, T.Y., Law, C.K., Tsoi, Y.K., and Leung, K.S., 2012. Review of Biological and Pharmacological Activities of the Endemic Taiwanese Bitter Medicinal Mushroom, Antrodia camphorata (M. Zang et C. H. Su) Sh. H. Wu et al. (Higher Basidiomycetes). Int J Med Mushrooms 14, 241-56.
Zhang, X.Y., Chen, J., Zheng, Y.F., Gao, X.L., Kang, Y., Liu, J.C., Cheng, M.J., Sun, H., and Xu, C.J., 2009. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo. Cancer Res 69, 6506-14.
Zheng, L.D., Tong, Q.S., and Wu, C.H., 2002. [Inhibitory effects of curcumin on apoptosis of human ovary cancer cell line A2780 and its molecular mechanism]. Ai Zheng 21, 1296-300.
吳佳燕, 2011. 牛樟芝子實體萃取物對於人類大腸癌細胞株caco-2之細胞凋亡機制探討. 國立東華大學生物技術研究所碩士論文.李順來, 2009. 牛樟芝台灣國寶. 世茂出版有限公司, 台灣.
李嘉偉, 2011. 牛樟芝子實體活性成分抑制前列腺癌之作用機轉. 國立東華大學生物技術研究所碩士論文.林永浩, 2004. 牛樟芝之牛樟樹宿主專一性. 食品工業, 14.高翊愷, 2011. 牛樟芝子實體萃取物對於人類肝癌細胞株HepG2之細胞凋亡機制探討. 國立東華大學生物技術研究所碩士論文.許勝傑、陳清農、陳勁初, 2000. 牛樟芝宿主專一性之探討. 台灣農業化學與食品科學, 7.陳懿妗, 2009. 結合液固態培養及微生物誘導牛樟芝菇化之研究. 國立東華大學生物技術研究所碩士論文.程一華, 1993. 樟芝之成份研究. 國立台灣師範大學化學研究所碩士論文.黃惟敏, 1999. 樟芝微量成分的研究(二). 私立靜宜大學食品科學研究所碩士論文.羅仁傑, 2010. 牛樟芝中抑制血管新生活性成分之研究. 國立東華大學生物技術研究所碩士論文.